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The formation of macromolecular complexes, for exam-
ple the complex between an antibody and an antigen, is
essential to many biological processes. In order to gain a
better insight into the biological processes involved, the
formation of complexes is often measured and their inter-
action kinetics and affinities analyzed. Considerable effort
has been expended in developing techniques to measure
the formation of complexes, the most promising being
electronic microchip-based biosensors. Such analytical
systems have come into increasing use recently for the
characterization of interactions between biological macro-
molecules and ligands. One such commercially available
system, called BlAcore (Pharmacia Biosensor, Uppsala,
Sweden), uses bitsensor-based technology and offers a
method for rapid analysis of interaction kinetics and affini-
ties 11,2]. Such systems have the advantage of replacing
tedious binding assays utilizing radiolabelled or fluorescent
components and potentially unstable cell lines, and can be
used where biological activity assays are not available.
The BlAcore system contains a sensor microchip, a laser
light source emitting polarized light, an automated fluid-
handling system [41, and a diode-array position-sensitive
detector (Fig. 1). The sensor chip consists of a glass sup-
port, an overlaid gold film and a carboxymethylated dex-
tran matrix [51 to which biomolecules can be coupled
(Fig. 1). To study interactions between biomolecules, this
system uses a surface plasmon resonance (SPR)-based
assay, an optical technique that measures changes in the
refractive index at the sensor chip surface. When plane-
polarized light is incident on the sensor chip at an angle
greater than a defined critical angle, and the intensity of
the reflected light is monitored using a position-sensitive
detector, SPR is observed as a decrease in light intensity
for a specific angle of incidence (the SPR angle) [1,21.
The angle at which the decrease in light intensity occurs is
proportional to the refractive index at the sensor chip; this
is in turn proportional to surface mass changes. To study
interactions between two molecules, one of the molecules
is covalently immobilized on the sensor chip and the sec-
ond molecule is injected over the chip surface. Inter-
actions between the two molecules result in mass changes
at the chip surface, which translate to refractive index
changes and changes in the SPR angle. Changes in SPR
angles are monitored as resonance units (RU, where 1000
RU corresponds to a 0.1()00 change in SPR angle, a 1.0 ng
nmm- 2 change in surface mass, and a bulk refractive index
change of 0.001) 11]. RU value shifts may occur either in
response to specific binding to the immobilized molecule,
or in response to differences in buffer compositions. Non-
specific RU value changes can be distinguished from a
specific response by carrying out blank injections, of
buffer only or buffer plus a non-specific control protein,
over the chip surface.
The coupling of biomolecules to the sensor chip surface
is accomplished using amine, thiol or aldehyde-based
immobilizations [6,7]. When a defined orientation of a
protein molecule is required, cysteine residues can be
introduced at specific sites in the protein to allow orien-
ted coupling. A knowledge of the isoelectric point (pl) of
the sample to be immobilized is useful before attempting
coupling to the sensor chip. It is necessary to prepare the
sample of macromolecule to be coupled in a buffer with
a pH value below the pI, in order to enhance electrosta-
tic interactions with carboxyl groups on the sensor chip.
Various parameters in addition to pH can influence pro-
tein immobilization levels. These include the ionic
strength of the buffer, the protein concentration and the
duration of the coupling reaction. For proteins that are
refractive to coupling using the methods described above,
an alternative immobilization strategy involves biotiny-
lation followed by binding to commercially available
streptavidin-coated sensor chips.
Fig. 1. The principle of operation of the optical biosensor in
BlAcore. (Adapted from 127].)
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Fig. 2. Representative sensorgram data
showing the binding of IgG to the
neonatal Fc receptor (FcRn) immobi-
lized on a biosensor chip. The figure
illustrates difference sensorgrams for
identical injections onto flowcells of
a sensor chip that either have FcRn
coupled or have a 'blank' coupling
(RUFcRn flowcell-RUblank flowcell), in order
to remove RU contributions due to
buffer substances and salts in the
injected samples. Two concentrations of
IgG were injected during a sample pulse
of about 6 min at a flow rate of 5 1l
min-, corresponding to the association
phase. Dissociation was subsequently
monitored in buffer at pH 6.0 or at pH
7.5. At pH 7.5 the dissociation rate of
the complex is very rapid, as visualized
by the steep change in RU.
The data derived from the BlAcore system are in the
form of sensorgrams, which are plots of RU versus time.
Progress of association and dissociation events between
molecules can thus be followed in real time. As an
example, Fig. 2 shows representative sensorgrams
derived for the binding of two concentrations of IgG to
a soluble form of the neonatal constant framework of
antibody Fc receptor (FcRn) [8], which was immobi-
lized on a sensor chip. The data are shown as sensor-
grams resulting from the difference in RU between
identical injections onto the flow cells of a sensor chip,
to which were coupled either FcRn or buffer. The end
of the flow of sample through the cell (association phase)
is at about 450 s. The complex dissociates in two steps:
the first dissociation step is in a buffer of pH 6.0, and the
second dissociation step, initiated at about 950 s, is in
buffer of pH 7.5. This experiment illustrates the marked
instability of the FcRn-IgG interaction at pH 7.5, a
well-known feature of this receptor [9] that is important
physiologically for the efficient unidirectional transport
of IgG from the gut (pH 6.0-6.5) into the blood
(pH 7.0-7.5). Visual inspection of the sensorgrams illus-
trates that the dissociation rate of the FcRn-IgG com-
plex is significantly faster at pH 7.5 than at pH 6.0.
Estimates of association and dissociation rate constants
can be obtained from sensorgrams, using either lin-
earized transformations of primary data [10] or non-lin-
ear curve-fitting methods [11]. Use of the recently
developed BlAevaluation 2.0 software package enables
rapid non-linear analysis of BlAcore-generated data
using the Marquardt-Levenberg curve-fitting routine
[12]. Affinity constants from experiments in which the
interaction reaches equilibrium during the sample injec-
tion can also be determined by a method similar to
Scatchard analysis (see BlAcore methods manual or
[13]). Equilibrium analyses are especially useful when
the association and/or dissociation kinetics are too rapid
to be measured accurately, as for the dissociation rate of
the FcRn-IgG complex at pH 7.5 (Fig. 2).
A look at the literature reveals diverse uses of BlAcore-
biosensor technology, including identification of specific
protein-protein interactions in complex systems [14-17],
mapping of binding sites [18-20], identification of lig-
ands for receptors from crude cellular supernatants [21],
and investigations of kinetic parameters for previously
characterized interactions [22]. From the perspective of a
structural biologist, the BIAcore system offers a conve-
nient tool with which to dissect intermolecular interfaces
using proteins engineered with site-directed mutations.
Cunningham and Wells [23] have carried out a compre-
hensive analysis of the energetic importance of 31
residues buried at the interface between human growth
hormone (hGH) and the extracellular region of its recep-
tor (hGHbp), deduced from the crystal structure of the
complex [24]. Each of the 31 side chains in hGH was
changed to alanine and the kinetics and affinities of inter-
action with hGHbp were measured using BlAcore assays.
The study revealed that as few as a quarter of the side
chains, clustered near the center of the interface,
accounted for most of the binding energy [23]. These
results, and more recent studies with alanine mutants of
hGHbp [25], suggest a differentiation between a struc-
tural epitope (those residues at the intermolecular inter-
face determined from a structural analysis) and a
functional epitope (those contact residues that provide
the majority of the stabilization energy for the complex).
The conclusion from the structural and functional analy-
sis of the hGH-hGHbp complex was that only a small
and complementary subset of the total contact residues
was required for maintaining binding affinity [25]. Fur-
ther studies with other systems should verify the general-
ity of these conclusions, but the authors [25] suggest that
these results may also be characteristic of other
protein-protein interfaces.
Crystal structure characterization can reveal higher-order
structures that may turn out to be either functionally
important, or an artifact of crystallization conditions.
Further experiments using BlAcore technology can be
designed to test the relevance of such structures. We have
tested the biological relevance of an Fc receptor dimer
that was crystallographically observed [26], by designing
a receptor whose ability to dimerize was impaired when
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coupled via a cysteine residue that was introduced at the
dimer interface. Ligand binding by such a dimerization-
impaired receptor was compared with ligand binding by
a dimerization-competent receptor. It was deduced that
the crystallographically observed Fc receptor dimer was
important for high-affinity ligand binding (M Raghavan,
YP Wang and PJ Bjorkman, unpublished data).
In combination with recombinant DNA technology for
generating mutant proteins, biosensor-based functional
assays are becoming essential tools in the structural biology
laboratory. BlAcore is one such system that can be used
conveniently to test structural predictions of possible con-
tact sites, to examine contributions of individual residues
at intermolecular interfaces to the overall binding energy,
and to demonstrate the validity of proposed functional
models. The diversity of applications of such systems will
no doubt continue to expand in the coming months.
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